Canterbury DHB


Monitoring of Treatment

Adequacy of treatment is determined by appropriate treatment of symptoms. If flushing, sweating and other estrogen deficiency symptoms continue to occur then the dose of oestrogen may need to be increased. It is not useful to check FSH levels as these may remain elevated despite adequate doses of estrogen. Likewise many of the forms of estrogen (e.g. Premarin) do not alter blood estradiol levels and measuring this can be misleading.

About this Canterbury DHB document (22134):

Document Owner:

Sean Macpherson (see Who's Who)

Last Reviewed:

January 2019

Next Review:

January 2022


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 22134